Getting to a brick and mortar healthcare and research facility isn’t always practical or convenient. Luckily, remote monitoring and other decentralized ways of collecting data are on the rise. Hospitals are finding remote patient monitoring (RPM) equipment to have a strong ROI. The University of Pittsburgh Medical Center reduced hospital readmissions by 76% and held a patient satisfaction score of over 90% by merely equipping patients with tablets and RPM equipment. 
Similarly, virtual clinical trials can significantly reduce costs and time involved in a traditional trial. Nearly 70% of potential clinical trial participants live more than two hours away from a study center, limiting their opportunities to benefit from possibly life-changing therapies.  Virtual trials open patient recruitment far beyond the geographical limitations of site-based clinical trials. Remote trials also have the potential to improve patient retention, expand the diversity of the patient population, and allow for greater patient compliance.
It’s evident that remote monitoring via telemedicine and portable devices has many benefits, but do the positives outweigh the potential risks? What are the regulatory, data privacy, cybersecurity, and technical considerations for scaling of such solutions?
Key experts in the field will discuss the current landscape of digital technologies aimed at decentralizing clinical trials, making them more efficient and bringing them closer to where most patients live.